Acute insomnia and clinical strategy of risk modification in patients with chronic non-communicable diseases

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Acute insomnia (synonyms: short-term, adaptive, situational) is a disease with a characteristic disorder of sleep initiation and/or maintenance with the development of excessive daytime sleepiness syndrome, loss of daytime activity stimuli, limited in duration to a period from 1–2 weeks to 3 months. Despite the existing strategies of drug and non-drug correction, therapy of acute insomnia in patients with chronic non-communicable diseases (CNCDs) remains highly controversial. In this review, we analyzed the data of systematic meta-analyses and randomized clinical trials (RCTs) that expand our understanding of the mechanisms of acute insomnia development in patients with СNCDs, as well as new strategies for risk modification and correction of sleep disorders that are effective in real-life clinical practice.

全文:

受限制的访问

作者简介

Sergey Babak

Russian University of Medicine

编辑信件的主要联系方式.
Email: sergbabak@mail.ru
ORCID iD: 0000-0002-6571-1220
SPIN 代码: 5213-3620
Scopus 作者 ID: 45560913500
Researcher ID: KAO-3183-2024

Dr. Sci. (Med.), Associate Professor, Professor, Department of Phthisiology and Pulmonology, Research Institute of Clinical Medicine n.a. N.A. Semashko

俄罗斯联邦, Moscow

Marina Gorbunova

Russian University of Medicine

Email: mgorb@mail.ru
ORCID iD: 0000-0002-2039-0072
Scopus 作者 ID: 45561369300

Dr. Sci. (Med.), Associate Professor at the Department of Phthisiology and Pulmonology, Research and Educational Institute of Clinical Medicine named after N.A. Semashko

俄罗斯联邦, Moscow

Andrey Malyavin

Russian University of Medicine

Email: maliavin@mail.ru
ORCID iD: 0000-0002-6128-5914
SPIN 代码: 8264-5394
Scopus 作者 ID: 6701876872

Dr. Sci. (Med.), Professor at the Department of Phthisiology and Pulmonology, Research and Educational Institute of Clinical Medicine named after N.A. Semashko

俄罗斯联邦, Moscow

参考

  1. Hale L., Troxel W., Buysse D.J.. Sleep Health: An Opportunity for Public Health to Address Health Equity. Annu Rev Public Health. 2020 Apr 2;41:81–99. https://doi.org/10.1146/annurev-publhealth-040119-094412
  2. Sateia M.J. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014 Nov;146(5):1387–1394. doi: 10.1378/chest.14-0970
  3. Momin R.R., Aslam S.P., Ketvertis K. Short-Term Insomnia. 2025 Apr 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
  4. Gauld C., Lopez R., Geoffroy P.A., et al. A systematic analysis of ICSD-3 diagnostic criteria and proposal for further structured iteration. Sleep Med Rev. 2021 Aug; 58:101439. https://doi.org/10.1016/j.smrv.2021.101439
  5. Голенков А.В., Полуэктов М.Г. Распространенность нарушений сна у жителей Чувашии (данные сплошного анкетного опроса). Журнал неврологии и психиатрии им. С.С. Корсакова. 2011;111(6):64–67. [Golenkov A.V., Poluektov M.G. Prevalence of sleep disorders among residents of Chuvashia (data from a comprehensive questionnaire survey). S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(6):64–67. (In Russ.)].
  6. San L., Arranz B. The Night and Day Challenge of Sleep Disorders and Insomnia: A Narrative Review. Actas Esp Psiquiatr. 2024 Feb;52(1):45–56.
  7. Van Someren E.J.W. Brain mechanisms of insomnia: new perspectives on causes and consequences. Physiol Rev. 2021 Jul 1;101(3):995–1046. doi: 10.1152/physrev.00046.2019
  8. Espie C.A. What Is Insomnia? In: The Clinician’s Guide to Cognitive and Behavioural Therapeutics (CBTx) for Insomnia: A Scientist-Practitioner Approach. Cambridge University Press; 2025:35–56. https://doi.org/10.1017/9781108989480
  9. Spielman A.J., Caruso L.S., Glovinsky P.B. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987 Dec;10(4):541-53.
  10. Palagini L., Geoffroy P.A., Gehrman P.R., et al. Potential genetic and epigenetic mechanisms in insomnia: A systematic review. J Sleep Res. 2023 Dec;32(6):e13868. https://doi.org/10.1111/jsr.13868
  11. Leerssen J., Lakbila-Kamal O., Dekkers L.M.S., et al. Treating Insomnia with High Risk of Depression Using Therapist-Guided Digital Cognitive, Behavioral, and Circadian Rhythm Support Interventions to Prevent Worsening of Depressive Symptoms: A Randomized Controlled Trial. Psychother Psychosom. 2022;91(3):168-179. https://doi.org/10.1159/000520282
  12. Reesen J.E., van de Kamer F.M., van Keeken A.E., et al. Applying therapist-guided digital cognitive behavioral therapy for insomnia in psychiatry: a mixed-methods process evaluation. BMC Psychiatry. 2025 Apr 28;25(1):428. https://doi.org/10.1186/s12888-025-06824-1
  13. Riemann D., Dressle R.J., Benz F., Spiegelhalder K., et al. Chronic insomnia, REM sleep instability and emotional dysregulation: A pathway to anxiety and depression? J Sleep Res. 2025 Apr;34(2):e14252. https://doi.org/10.1111/jsr.14252
  14. Spiegel K., Sheridan J.F., Van Cauter E. Effect of sleep deprivation on response to immunization. JAMA. 2002 Sep 25;288(12):1471–2. https://doi.org/10.1001/jama.288.12.1471-a
  15. Zhu B., Shi C., Park C.G., Zhao X., Reutrakul S. Effects of sleep restriction on metabolism-related parameters in healthy adults: A comprehensive review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2019 Jun;45:18-30. https://doi.org/10.1016/j.smrv.2019.02.002
  16. Imeri L., Opp M.R. How (and why) the immune system makes us sleep. Nat Rev Neurosci. 2009 Mar;10(3):199–210. doi: 10.1038/nrn2576
  17. Gottlieb D.J., Punjabi N.M., Newman A.B., et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. 2005 Apr 25;165(8):863–7. doi: 10.1001/archinte.165.8.863
  18. Cappuccio F.P., Cooper D., D’Elia L., et al. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011 Jun;32(12):1484–92. doi: 10.1093/eurheartj/ehr007
  19. Kessler R.C., Berglund P.A., Coulouvrat C., et al. Insomnia and the performance of US workers: results from the America insomnia survey. Sleep. 2011 Sep 1;34(9):1161–71. https://doi.org/10.5665/SLEEP.1230 Erratum in: Sleep. 2011;34(11):1608. Erratum in: Sleep. 2012 Jun 1;35(6):725. https://doi.org/10.5665/sleep.1844
  20. Léger D., Bayon V., Ohayon M.M., Philip P., Ement P., Metlaine A., Chennaoui M., Faraut B. Insomnia and accidents: cross-sectional study (EQUINOX) on sleep-related home, work and car accidents in 5293 subjects with insomnia from 10 countries. J Sleep Res. 2014 Apr;23(2):143–52. https://doi.org/10.1111/jsr.12104
  21. Buysse D.J. Insomnia. JAMA. 2013 Feb 20;309(7):706–16. https://doi.org/10.1001/jama.2013.193
  22. Krystal A.D., Ashbrook L.H., Prather A.A. What Is Insomnia? JAMA. 2021 Dec 21;326(23):2444. https://doi.org/10.1001/jama.2021.19283
  23. Модифицируемые факторы риска для достижения здорового долголетия: 10 шагов к здоровому образу жизни. Розанов А.В., Бабак С.Л., Скородумова Е.Г. Москва: АМСМР, 2025. 40 с. [Modifiable risk factors for achieving healthy longevity: 10 steps to a healthy lifestyle. Rozanov A.V., Babak S.L., Skorodumova E.G. Moscow, 2025. 40 p. (In Russ.)].
  24. Kloss J.D., Nash C.O., Walsh C.M., et al. A «Sleep 101» Program for College Students Improves Sleep Hygiene Knowledge and Reduces Maladaptive Beliefs about Sleep. Behav Med. 2016;42(1):48–56. https://doi.org/10.1080/08964289.2014.969186
  25. Riemann D., Baglioni C., Bassetti C., et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017 Dec;26(6):675–700. https://doi.org/10.1111/jsr.12594
  26. Riemann D., Espie C.A., Altena E., et al. The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. J Sleep Res. 2023 Dec;32(6):e14035. https://doi.org/10.1111/jsr.14035
  27. Simons F.E., Simons K.J. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol. 2011 Dec;128(6):1139–1150.e4. https://doi.org/10.1016/j.jaci.2011.09.005
  28. Левин Я.И., Стрыгин К.Н. Донормил в терапии инсомнии. Лечение нервных болезней. 2005;6(2):16. [Levin Ya.I., Strygin K.N., Donormil v terapii insomnii. Lechenie nervnykh boleznei. 2005;6(2):16. (In Russ.)].
  29. Slaughter S.R., Hearns-Stokes R., van der Vlugt T., Joffe H.V. FDA approval of doxylamine-pyridoxine therapy for use in pregnancy. N Engl J Med. 2014 Mar 20;370(12):1081–3. https://doi.org/10.1056/NEJMp1316042
  30. Мельников А.Ю., Лаврик С.Ю., Бикбулатова Л.Ф. и др. Эффективность препарата реслип (доксиламин) при острой инсомнии: многоцентровое открытое сравнительное рандомизированное исследование. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2017;117(4 2):56–59. [Melnikov A.Yu., Lavrik S.Yu., Bikbulatova L.F., et al. Effectiveness of reslip (doxylamine) in short-term insomnia: multicenter comparative randomized study. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(4-2):56–59. (In Russ.)]. https://doi.org/10.17116/jnevro20171174256-59
  31. De Crescenzo F., D’Alò G.L., Ostinelli E.G., et al. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet. 2022 Jul 16;400(10347):170–184. https://doi.org/10.1016/S0140-6736(22)00878-9
  32. Драпкина О.М., Концевая А.В., Калинина А.М. и др. Профилактика хронических неинфекционных заболеваний в Российской Федерации. Национальное руководство 2022. Кардиоваскулярная терапия и профилактика. 2022;21(4):3235. [Drapkina O.M., Kontsevaya A.V., Kalinina A.M., et al. Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines 2022. Cardiovascular therapy and prevention. 2022;21(4):3235. (In Russ.)]. https://doi.org/10.15829/1728-8800-2022-3235

补充文件

附件文件
动作
1. JATS XML
下载
2. Figure 1. Schematic representation of the 3-stage model of insomnia

下载 (427KB)
索引源数据
3. Figure 2. Illustrative tips for the patient on proper sleep hygiene

下载 (668KB)
索引源数据

版权所有 © Bionika Media, 2025